Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zynrelef for pain after retropubic mid-urethral sling surgery
NCT05702827Phase 3Completed
- Sponsor
- TriHealth
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine + meloxicam in postoperative pain, sponsored by TriHealth. Primary endpoint: Post-operative narcotic use at 72 hours. Started Jan 2023; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05702827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702827.